HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

Manylion Llyfryddiaeth
Prif Awduron:	Orkin, C, Montoto, S, Shaw, K, Okosun, J, Gandhi, S, Fields, P, Wilson, A, Shanyinde, M, Cwynarski, K, Marcus, R, De Vos, J, Young, A, Tenant-Flowers, M, Johnson, M, Chilton, D, Gribben, J, Bower, M
Fformat:	Journal article
Cyhoeddwyd:	2012

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
gan: Montoto, S, et al.
Cyhoeddwyd: (2011)

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
gan: Montoto, S, et al.
Cyhoeddwyd: (2012)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
gan: Bhanu Vakkalanka, et al.
Cyhoeddwyd: (2011-01-01)

The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
gan: Adam F. Binder, et al.
Cyhoeddwyd: (2017-10-01)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
gan: Diego Villa, et al.
Cyhoeddwyd: (2018-12-01)

Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case report
gan: Subbiah Vivek, et al.
Cyhoeddwyd: (2007-11-01)

S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY
gan: J. P. Entrop, et al.
Cyhoeddwyd: (2022-06-01)

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
gan: Paolo Strati, et al.
Cyhoeddwyd: (2019-02-01)

A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
gan: Ryo Yonezawa, et al.
Cyhoeddwyd: (2023-01-01)

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
gan: Schwenkglenks Matthias, et al.
Cyhoeddwyd: (2010-08-01)

Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
gan: Camille Cotteret, et al.
Cyhoeddwyd: (2020-04-01)

Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context
gan: Marriam Mponda, et al.
Cyhoeddwyd: (2024-03-01)

Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation
gan: Rebecca J. DeBoer, et al.
Cyhoeddwyd: (2020-11-01)

Advanced Hodgkin's lymphoma: results in 216 patients treated with ABVD in Brazil Linfoma de Hodgkin em estádio avançado: resultados do tratamento em 216 pacientes tratados com ABVD no Brasil
gan: Luciana Britto, et al.
Cyhoeddwyd: (2010-01-01)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
gan: Min Hu, et al.
Cyhoeddwyd: (2023-08-01)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
gan: Joshua P. Entrop, et al.
Cyhoeddwyd: (2022-10-01)

PB2260: FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD
gan: Vojin Vukovic, et al.
Cyhoeddwyd: (2023-08-01)

Clinical profile and outcome of classical Hodgkin lymphoma treated with ABVD protocol at Homi Bhabha Cancer Hospital Varanasi
gan: NIKITA SINGH, et al.
Cyhoeddwyd: (2022-01-01)

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD
gan: Chakraborty R, et al.
Cyhoeddwyd: (2015-03-01)

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
gan: Heidi Mocikova, et al.
Cyhoeddwyd: (2022-10-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
gan: Arun Seshachalam, et al.
Cyhoeddwyd: (2019-12-01)

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
gan: Jillian R. Gunther, et al.
Cyhoeddwyd: (2020-07-01)

Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.
gan: Greaves, P, et al.
Cyhoeddwyd: (2013)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Cyhoeddwyd: (2018-10-01)

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
gan: Marc P. E. André, et al.
Cyhoeddwyd: (2020-09-01)

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
gan: Alessandro Cellini, et al.
Cyhoeddwyd: (2024-09-01)

Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
gan: Massimo Federico, et al.
Cyhoeddwyd: (2016-04-01)

Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource‐limited country: An observational study
gan: Tawatchai Suwanban, et al.
Cyhoeddwyd: (2023-08-01)

P1081: PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH-05 TRIAL
gan: A. Pavlovsky, et al.
Cyhoeddwyd: (2022-06-01)

Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
gan: Rogério Pinto Giesta, et al.
Cyhoeddwyd: (2009-06-01)

FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin’s disease-a useful tool for monitoring pulmonary toxicity and disease activity
gan: T. Buchler, et al.
Cyhoeddwyd: (2007-11-01)

A comparison of clinical profile and treatment outcome of Hodgkin’s Lymphoma in Tanzania according to HIV status during the HAART era
gan: Mercy M. Mbai, et al.
Cyhoeddwyd: (2024-07-01)

Pilot study of lung cancer screening for survivors of Hodgkin lymphoma
gan: Rachel Broadbent, et al.
Cyhoeddwyd: (2023-11-01)

P030 (0143) ONCE-A-CYCLE VS. DAILY G-CSF IN EARLY-UNFAVORABLE STAGES OF HODGKIN LYMPHOMA TREATED WITH BEACOPP ESCALATED FOLLOWED BY ABVD
Cyhoeddwyd: (2018-10-01)

P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA
gan: N. L. Fiad, et al.
Cyhoeddwyd: (2022-06-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
gan: Ercole Brusamolino, et al.
Cyhoeddwyd: (2012-04-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
gan: Ercole Brusamolino, et al.
Cyhoeddwyd: (2014-08-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
gan: Ercole Brusamolino, et al.
Cyhoeddwyd: (2012-01-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
gan: Ercole Brusamolino, et al.
Cyhoeddwyd: (2014-08-01)

P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.
gan: Michael Dickinson, et al.
Cyhoeddwyd: (2023-08-01)

HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

Eitemau Tebyg

Eitemau Tebyg